Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.
Åse BratlandEva Muñoz CouseloLaurent MortierOsama RoshdyRene GonzálezJacob SchachterAna M AranceFlorent GrangeNicolas MeyerAbhishek Jagdish JoshiSalem BillanBrett G M HughesJean-Jacques GrobKarthik RamakrishnanJoy GeBurak GumuscuRamona F SwabyRalf GutzmerPublished in: Dermatology and therapy (2023)
ClinicalTrials.gov, NCT03284424-September 15, 2017.